These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11202979)

  • 1. 22nd congress of the European Society of Cardiology, Amsterdam.
    Wroe CD
    Int J Clin Pract; 2000 Sep; 54(7):459-60. PubMed ID: 11202979
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].
    Obradović S; Gligić B; Djordjević D; Jovicić A; Romanović R; Ratković N; Dincić D; Orozović V; Nikolić G
    Vojnosanit Pregl; 2001; 58(1):65-72. PubMed ID: 11419288
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet glycoprotein IIb/IIIa integrin inhibition in acute myocardial infarction.
    O'Shea C; Tcheng JE
    J Invasive Cardiol; 1999 Aug; 11(8):494-9. PubMed ID: 10745582
    [No Abstract]   [Full Text] [Related]  

  • 4. Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction.
    Moliterno DJ; Topol EJ
    Thromb Haemost; 1997 Jul; 78(1):214-9. PubMed ID: 9198156
    [No Abstract]   [Full Text] [Related]  

  • 5. IIb/IIIa inhibitors in acute myocardial infarction.
    Montalescot G
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S71-5. PubMed ID: 10070824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Society of Cardiology 2000. Amsterdam, The Netherlands, 26-30 August, 2000.
    Davies C
    Heart Fail Monit; 2001; 1(3):107-9. PubMed ID: 12638573
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients.
    Keularts IM; Béguin S; de Zwaan C; Hemker HC
    Thromb Haemost; 1998 Sep; 80(3):370-1. PubMed ID: 9759611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein IIb/IIIa inhibitors and the guidelines for treatment of non-ST-elevation myocardial infarction.
    Coplan NL
    J Am Coll Cardiol; 2004 Mar; 43(5):926-7; author reply 927-8. PubMed ID: 14998642
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
    Antman EM
    Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relations of major platelet receptor expression during myocardial infarction. Monitoring efficacy of GPIIb/IIIa inhibitors by measuring P-selectin?
    Serebruany VL; Gurbel PA
    Thromb Haemost; 1999 Feb; 81(2):314-6. PubMed ID: 10064014
    [No Abstract]   [Full Text] [Related]  

  • 11. Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation.
    Vavalle JP; Rao SV
    Adv Cardiol; 2012; 47():125-40. PubMed ID: 22906908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
    Patel VB; Moliterno DJ
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycoprotein IIb/IIIa inhibition and long-term benefit: the stuff of dreams?
    Montalescot G
    Eur Heart J; 2004 Sep; 25(18):1562-4. PubMed ID: 15351154
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitors of platelet glycoprotein IIb/IIIa as augmenters of thrombolysis.
    Eccleston D; Topol EJ
    Coron Artery Dis; 1995 Dec; 6(12):947-55. PubMed ID: 8723017
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes.
    Melandri G
    Lancet; 2001 Dec; 358(9297):1997. PubMed ID: 11747953
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal timing for use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: questions, answers, and more questions.
    Mahaffey KW; Harrington RA
    JAMA; 2007 Feb; 297(6):636-9. PubMed ID: 17299199
    [No Abstract]   [Full Text] [Related]  

  • 17. Could clopidogrel's platelet inhibition be enhanced by an increased loading dose and eptifibatide?
    Kleiman NS
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):344-5. PubMed ID: 16265559
    [No Abstract]   [Full Text] [Related]  

  • 18. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Pereira H;
    Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
    [No Abstract]   [Full Text] [Related]  

  • 19. Upstream/downstream glycoprotein IIb/IIIa in non-ST-segment elevation myocardial infarction.
    Ben-Yehuda O
    J Am Coll Cardiol; 2006 Feb; 47(3):538-40. PubMed ID: 16458132
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet disaggregation: putting time on your side in acute myocardial infarction.
    Simon DI; Sakuma M
    J Am Coll Cardiol; 2004 Jul; 44(2):324-6. PubMed ID: 15261926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.